24.48000 USD
0.72
2.86%
Last update Dec 18, 3:59 PM EST
Post-market
Day range
24.25
25.74000
Previous close
25.20000
Open
25.31000
Access this stock data via API
Subscribe
Apellis Pharmaceuticals Inc.
24.48
0.72
2.86%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 458.6M 178.5M 166.8M 212.5M
Cost of revenue 24.5M 13.6M 34.4M 40.9M
Gross profit 434.0M 164.9M 132.4M 171.7M
Operating expense
Research & development 68.2M 67.0M 86.4M 76.4M
Selling general and admin 142.7M 131.1M 129.3M 121.5M
Other operating expenses
Operating income 223.2M -33.3M -83.3M -26.2M
Non operating interest income
Income 4.4M 2.6M 2.7M 3.4M
Expense 11.3M 11.2M 11.0M 11.5M
Other income expense 37K 146K -165K -1.8M
Pretax income 216.3M -41.7M -91.9M -36.1M
Tax provision 602K 466K 341K 286K
Net income 215.7M -42.2M -92.2M -36.4M
Basic EPS 1.7 -0.3 -0.7
Diluted EPS 1.7 -0.3 -0.7
Basic average shares 126.4M 126.0M 125.5M
Diluted average shares 130.1M 126.0M 125.5M
EBITDA 227.9M -30.1M -80.4M -24.1M
Net income from continuing op. 215.7M -42.2M -92.2M -36.4M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Post-market

Exchange is currently open for post-market.
Post market session closes in 1 hour 9 minutes

18:51
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).